The rules for predicting remission in patients with Cushing disease after successful endoscopic transnasal adenomectomy
BACKGROUND: The recurrence rate after successful transnasal adenomectomy in Cushings disease (CD) can reach 47%. We have previously shown that patients with ACTH levels less than 7 pg/ml recurred over 3 years 4.5 times less often than patients with higher levels of ACTH, patients with cortisol level...
Gespeichert in:
Veröffentlicht in: | Problemy ėndokrinologii 2020-08, Vol.66 (1), p.70-77 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng ; rus |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | BACKGROUND: The recurrence rate after successful transnasal adenomectomy in Cushings disease (CD) can reach 47%. We have previously shown that patients with ACTH levels less than 7 pg/ml recurred over 3 years 4.5 times less often than patients with higher levels of ACTH, patients with cortisol levels below 123 nmol/l in 3.4 times less than at higher values of this hormone, however, these indicators are dissociated in 41% of cases, so it is not possible use them for prediction separately.
AIM: To develop a method for managing patients after successful transnasal adenomectomy depending on prognosis.
METHODS: A monocenter retrospective comparative study included 349 patients (52 men, 297 women) with a confirmed diagnosis of CD, who underwent effective endoscopic transsphenoidal adenomectomy in 20072014. Various combinations of postoperative morning levels of ACTH and cortisol were analyzed.
RESULTS: Based on the developed forecasting methods and their best characteristics, the following rules were formulated. If postoperative morning ACTH is less than 7 pg/ml and/or postoperative morning cortisol is less than 123 nmol/l, then the patient will remain in remission for 1 year with probability of 99% (95% CI 97%100%) and for 3 years with probability of 86% (95% CI 80%91%).
CONCLUSION: The rules for predicting remission for 1 and 3 years for patients after neurosurgical treatment for CD are proposed. These rules are based on combinations of ACTH and cortisol levels. |
---|---|
ISSN: | 0375-9660 2308-1430 |
DOI: | 10.14341/probl10149 |